Similar Search Results

Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?

de Frutos, Maria-Angeles; Ornaghi, Carmine; Siotis, Georges - C.E.P.R. Discussion Papers - 2010

We present a Hotelling model of price and advertising competition between prescription drugs that differ in quality …/side e¤ects. Advertising results in the endogenous formation of two consumer groups: brand loyal and non-brand loyal ones. We … show that advertising strategies are strategic substitutes, with the better quality drugs being the ones that are most …

Persistent link: https://www.econbiz.de/10008680762

Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?

de Frutos, Maria-Angeles; Ornaghi, Carmine; Siotis, Georges - In: Journal of Health Economics 32 (2013) 1, pp. 268-285

We present a Hotelling model of price and advertising competition between prescription drugs that differ in quality …. We show that advertising intensities are strategic substitutes, with the better quality drugs being the ones that are … loyalty is endogenously determined by promotional effort. The model's main results on advertising and pricing strategies are …

Persistent link: https://www.econbiz.de/10010608419

Information content of advertising: Empirical evidence from the OTC analgesic industry

Anderson, Simon P.; Ciliberto, Federico; Liaukonyte, Jura - In: International Journal of Industrial Organization 31 (2013) 5, pp. 355-367

We develop an empirical study of the information–persuasion trade-off in advertising using data on the information …

Persistent link: https://www.econbiz.de/10010730051

Margins and market shares: Pharmacy incentives for generic substitution

Brekke, Kurt Richard; Holmås, Tor Helge; Straume, Odd Rune - In: European Economic Review 61 (2013) C, pp. 116-131

generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …

Persistent link: https://www.econbiz.de/10011048555

Pharmaceutical followers

Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - In: International Journal of Industrial Organization 31 (2013) 5, pp. 538-553

We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded …

Persistent link: https://www.econbiz.de/10011051621

Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment

Brekke, Kurt R.; Holmas, Tor Helge; Straume, Odd Rune - In: Journal of Public Economics 95 (2011) 7, pp. 624-638

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...

Persistent link: https://www.econbiz.de/10010574320

Margins and Market Shares: Pharmacy Incentives for Generic Substitution

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - CESifo - 2012

generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …

Persistent link: https://www.econbiz.de/10010603857

“BRANDED GENERICS” AS A STRATEGY TO LIMIT CANNIBALIZATION OF PHARMACEUTICAL MARKETS

Ward, Michael R.; Reiffen, David - Department of Economics, College of Business Administration - 2005

This paper demonstrates how, by introducing a generic version of its previously-patented product, a branded firm can influence the equilibrium in the generic segment of the market for the product. This in turn can increase the firm’s profits from selling the branded version. We then use...

Persistent link: https://www.econbiz.de/10005230146

EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals. What's blame? Derogation or perception?

Granlund, David; Yesim Köksal, Miyase - Nationalekonomiska institutionen, Handelshögskolan - 2011

Given the cost of trade and availability of pharmaceuticals, the driving force for parallel trade is the price … availability of pharmaceuticals for parallel trade should increase price competition in the destination country. Using 2003 …

Persistent link: https://www.econbiz.de/10010818749

Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure

Magazzini, Laura; Pammolli, Fabio; Riccaboni, Massimo - Volkswirtschaftliche Fakultät, … - 2004

distinction seems to emerge. On the one hand, systems that rely on market-based competition in pharmaceuticals promote a clear …

Persistent link: https://www.econbiz.de/10005034975